EAC MRH Programme 12 DEC 2019 GOAL To improve access to safe, - - PowerPoint PPT Presentation

eac mrh programme
SMART_READER_LITE
LIVE PREVIEW

EAC MRH Programme 12 DEC 2019 GOAL To improve access to safe, - - PowerPoint PPT Presentation

EAC MRH Programme 12 DEC 2019 GOAL To improve access to safe, efficacious and good quality essential medicines for the treatment of diseases of economic importance within EAC region and beyond. MRH PARTNERS WHO &SWISSMEDIC Technical


slide-1
SLIDE 1

EAC MRH Programme

12 DEC 2019

slide-2
SLIDE 2

GOAL

To improve access to safe, efficacious and good quality essential medicines for the treatment of diseases of economic importance within EAC region and beyond.

slide-3
SLIDE 3

MRH PARTNERS

WHO &SWISSMEDIC Technical Assistance (TA) to EAC Secretariat and Partner States NMRAs NEPAD Advocacy and political commitment in enactment of relevant policies and regulatory framework WORLD BANK Financial Management and oversight for the MRH Grant BMGF- Provides Financial Support PARTNER STATES

slide-4
SLIDE 4

MRH MRH MA MA

  • Harmonized

technical guidelines developed- 2012- 2014

  • Approved in Sep, 2019 by EAC

Council of Ministers

  • 2015

Adoption and domestication by EAC Partner States

  • 1st EOI for MA issued in Nov,

2015 - reproductive health products included

Harmonization process

slide-5
SLIDE 5

Joi Joint t as assessment

Process Flow chart including timelines

slide-6
SLIDE 6

JA A PROGRESS SS

  • Total applications: 106
  • Total assessed: 101
  • Total recommended: 50
  • Queried: 53
  • Under

evaluation: 7

(Distributed to Assessors)

  • Approved through MAGHP-4

Recommended Queried under evaluation Approved through MAGHP

slide-7
SLIDE 7

EAC-SWISSMEDIC COLLABORATION

  • Revision of existing

harmonized guidelines on MER and GMP-2018

  • Participation of

swissmedic and WHO experts in JA sessions -for clinical and quality review

  • f dossiers
  • Training of EAC experts
  • n MER and GMP
  • Training on case/project

management

slide-8
SLIDE 8

MA MAGH GHP

Global-

  • EAC is a member and participates at ICH and

ICDRA ( International Conference of Drug Regulatory Authorities) meetings

  • EAC experts participates in WHO PQ assessment

procedure Regional

  • Developed abridged guidelines to guide on the

assessment of products already approved through WHO PQ collaborative procedure to fast tract and reduce registration timeline- within 90 days

  • Convene joint dossier assessment sessions -13

sessions

  • Coordinates approval and registration of

recommended medical products

  • Capacity building of PS experts -participate in

the WHO PQ program

EAC Engagement

slide-9
SLIDE 9

MA MAGH GHP

Global

  • Participate in WHO PQ process

Regional and national

  • Domestication of harmonized

guidelines

  • Participation in EAC-MRH joint medical

product assessment and Good Manufacturing Practice Inspections

  • Registration of the approved products
  • Monitoring of Safety and quality of

products granted MA

  • Sharing of skills, experience, knowledge

and expertise through twinning programs

PS Engagement

slide-10
SLIDE 10

CON ONCLUSI SION

  • WHO and Swiss medic-

Technical Expertise

  • EAC Experts-Technical

expertise/capacity building

  • PS- Commitment / Financial

and technical Support

  • EAC Sec-

Staffing/Commitment, coordination/technical expertise/ capacity building

  • Partners- financial/ Technical

Commitment

Access of medicines is a collaborative process that require harmonized efforts

slide-11
SLIDE 11

One People, One Destiny Asante